STATE STREET CORP, a registered investment adviser, initiated a new position in Amgen Inc. (NASDAQ:AMGN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 30,591,403 shares of the Healthcare company, valued at approximately $10.0B as of the filing date.
Amgen Inc.'s stock currently trades at $365.67 with a market capitalization of $170.9B.